After 40, the list of tests with proven screening value is short. India's national programme screens adults aged 30 and above for blood pressure and diabetes once a year, and women and men aged 30 to 65 for oral, breast and cervical cancer once in five years (NP-NCD Training Module for Medical Officers, NHSRC/MoHFW, 2021). ICMR puts the starting age for diabetes screening at over 30, not 40 (ICMR Guidelines for Management of Type 2 Diabetes 2018, Section 2.1).
This page publishes the test list, the repeat interval and the fasting rule for each, and names the items that are commonly sold in a checkup panel but have no established screening value in a person with no symptoms. There is no package described here and no cost information anywhere on the page, because a package is a commercial object and a screening interval is a clinical one, and they are not the same thing.
One thing before the list. A health checkup is for a person who feels well. It is not the route for a symptom. AJSMC is an outpatient and day-care centre in Egmore, Chennai, open Monday to Saturday, 10am to 9pm, with no casualty unit and no emergency department, and ten beds for planned, stable admissions, with a nurse on site overnight and no doctor on the premises. Chest pain, sudden breathlessness, weakness down one side, slurred speech, fainting, or a severe headache of sudden onset is not a checkup question at all — call 108 or go straight to the nearest hospital with a 24-hour emergency department, at any hour, including when we are closed.
Which tests are actually worth doing after 40 in Chennai?
The ones below, because an Indian national body has named the population, the test and the interval. Everything else is a decision a doctor makes from your history and examination, not an item bought off a list. Note that the first item in the table is not a laboratory test at all, a blood pressure reading, like a body-weight and waist measurement, needs no fast and no needle.
| Test | Who, per Indian guidance | Interval if normal | Fasting needed | Source (year) |
|---|---|---|---|---|
| Blood pressure | All adults 30 and above | Once a year | No | NP-NCD population-based screening, MoHFW/NHSRC (2021) |
| Blood glucose — fasting plasma glucose, OGTT or random plasma glucose | All adults over 30; earlier if any risk factor is present | 3 years if normal; 1 year if prediabetes | 8 hours for a fasting sample; 8–10 hours plus 3 days of at least 200 g carbohydrate a day for an OGTT; none for a random sample | ICMR Guidelines for Management of Type 2 Diabetes 2018, Sections 2.1, 2.4 and 3.4 |
| HbA1c | Accepted by ICMR for screening, with stated Indian limitations | As above | No | ICMR 2018, Section 2.2 |
| Lipid profile | Part of cardiovascular risk factor assessment alongside glucose screening | Not fixed by ICMR 2018 — the doctor sets it from your risk | Not routinely; a non-fasting sample is recommended | ICMR 2018, Section 2.5; EAS/EFLM joint consensus, European Heart Journal 2016;37:1944–1958 |
| Oral cancer — visual examination of the mouth | Men and women 30–65 | Once in 5 years | No | NP-NCD Training Module for Medical Officers (2021) |
| Breast cancer — clinical breast examination | Women 30–65 | Once in 5 years | No | NP-NCD Training Module for Medical Officers (2021) |
| Cervical cancer — visual inspection with acetic acid (India); HPV DNA test (WHO) | Women 30–65 | Once in 5 years under the Indian programme; every 5 to 10 years from age 30 in WHO's guideline | No | NP-NCD Training Module for Medical Officers (2021); WHO guideline for screening and treatment of cervical pre-cancer (2021) |
Two honest caveats belong with that table. ICMR itself records that HbA1c "is also recommended for screening; however, in India there are some limitations regarding its use" (ICMR 2018, Section 2.2), so it is a convenient test, not automatically the right one for every patient in Chennai. And ICMR 2018 does not fix a repeat interval for the lipid profile the way it does for glucose, so anyone quoting you a firm lipid interval is quoting something other than ICMR.
Why does Indian guidance start at 30, not 40?
Because type 2 diabetes appears earlier in Indians. ICMR states that it occurs "at least a decade earlier" in Indians than in other major ethnic groups, and sets screening for all individuals over 30 years of age (ICMR 2018, Section 2, p.7). The American standard, for comparison, begins universal screening at 35 and repeats at a minimum of 3-year intervals if normal (ADA Standards of Care in Diabetes—2026). India's own body sets the bar five years earlier than the American one. If you are reading this at 42 in Chennai and have never had a sugar checked, you are twelve years past the Indian threshold, not two.
ICMR also lists the conditions under which screening should start earlier than 30. Any one of them is enough.
| Screen earlier than 30 if | The threshold ICMR gives |
|---|---|
| Family history of diabetes | Any |
| Overweight or central obesity | BMI 23 kg/m² or above, or waist above 90 cm in men and above 80 cm in women |
| Raised blood pressure | 130/80 mmHg or above, or already on treatment |
| Dyslipidaemia | Any |
| Sedentary activity level | Any |
| Past gestational diabetes or a large baby | Birth weight above 3.5 kg |
| Past ischaemic heart disease or cerebrovascular disease | Any |
| PCOS or acanthosis nigricans | Any |
Source: ICMR Guidelines for Management of Type 2 Diabetes 2018, Section 2.1, p.7. Note the BMI figure — 23 kg/m², not 25. A person who has been told all their adult life that they are not overweight can still meet this criterion on the Indian cut-off.
The national numbers explain why the interval matters more than the panel size. In the ICMR-INDIAB-17 survey of 113,043 people, published in Lancet Diabetes & Endocrinology in 2023, about one adult in six or seven had prediabetes, a group defined entirely by a blood test, because it has no symptoms at all.
| National prevalence, Indian adults | Figure |
|---|---|
| Diabetes | 11.4% (95% CI 10.2–12.5) |
| Prediabetes | 15.3% (13.9–16.6) |
| Hypertension | 35.5% |
| Generalised obesity | 28.6% |
| Abdominal obesity | 39.5% |
| Dyslipidaemia | 81.2% |
| Participants and survey period | 113,043 surveyed, 18 October 2008 to 17 December 2020 |
Source: Anjana RM et al., ICMR-INDIAB-17, Lancet Diabetes & Endocrinology 2023;11:474–489. These are national figures. State-level breakdowns for Tamil Nadu circulate widely online in forms that could not be verified against the published paper, so this page does not print one.
How long do I fast before a blood test, and can I drink water?
The fast belongs to the test, not to the visit. Only two of the tests on this page need one at all, and an overnight fast taken for any of the others serves no purpose. Fasting is defined by the American Diabetes Association as no caloric intake for at least 8 hours (ADA Standards of Care in Diabetes—2026) — plain water carries no calories, so water does not break it.
| Test | How long to fast | Plain water | What breaks the fast | Source (year) |
|---|---|---|---|---|
| Fasting plasma glucose | At least 8 hours with no caloric intake | Allowed | Tea or coffee with milk or sugar, juice, a biscuit, chewing gum, any food | ADA Standards of Care in Diabetes—2026 |
| Oral glucose tolerance test | Overnight fast of 8–10 hours, and a normal diet with at least 200 g of carbohydrate a day for at least 3 days beforehand | Allowed before the test; the glucose drink is part of the test itself | Any food or the fasting rule above; also eating or smoking between the two samples, and a low-carbohydrate diet in the days before, which can distort the result | ICMR 2018, Section 3.4 |
| HbA1c | No fast at all | Allowed | Nothing — eat normally | ADA Standards of Care in Diabetes—2026 |
| Lipid profile | Not routinely required | Allowed | Nothing routinely. A fasting repeat is advised only if the non-fasting triglycerides exceed 440 mg/dL, or in known high triglycerides | Nordestgaard BG, Langlois MR et al., EAS/EFLM joint consensus, European Heart Journal 2016;37:1944–1958 |
| Random plasma glucose | None, by definition | Allowed | Nothing | ICMR 2018, Section 3.1 |
| Blood pressure, weight, waist, oral, breast and cervical screening | None | Allowed | Nothing | NP-NCD Training Module for Medical Officers (2021) |
The single most useful correction here is the lipid row. The joint European Atherosclerosis Society and European Federation of Clinical Chemistry consensus concluded in 2016 that non-fasting samples should be used routinely for a lipid profile, with a fasting repeat only in the narrow circumstances above. A cholesterol test on its own is therefore not a reason to skip breakfast.
One safety point on fasting that applies to a specific group. If you already take medicine that lowers blood glucose, do not decide on your own to fast before a checkup — ask the doctor first, because an unnecessary fast on glucose-lowering treatment carries a risk of hypoglycaemia. Which test you actually need, and whether it requires a fast, is a question to settle before the morning of the visit rather than at the counter.






